Korean Post-marketing Surveillance for Xeljanz XR
NCT04876781
·
clinicaltrials.gov ↗
RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Active Moderate to Severe Rheumatoid Arthritis
Active Ankylosing Spondylitis
Active Psoriatic Arthritis
Interventions
DRUG:
Tofacitinib XR
Sponsor
Pfizer